Literature DB >> 27695883

ICU specialists facing terrorist attack: the Nice experience.

Jean-Christophe Orban1, Hervé Quintard1, Carole Ichai2,3.   

Abstract

Mesh：

Year:  2016        PMID： 27695883     DOI： 10.1007/s00134-016-4570-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  The medical response to multisite terrorist attacks in Paris.

Authors:  Martin Hirsch; Pierre Carli; Rémy Nizard; Bruno Riou; Barouyr Baroudjian; Thierry Baubet; Vibol Chhor; Charlotte Chollet-Xemard; Nicolas Dantchev; Nadia Fleury; Jean-Paul Fontaine; Youri Yordanov; Maurice Raphael; Catherine Paugam Burtz; Antoine Lafont
Journal:  Lancet       Date:  2015-11-28       Impact factor: 79.321

2.  Reduction in critical mortality in urban mass casualty incidents: analysis of triage, surge, and resource use after the London bombings on July 7, 2005.

Authors:  Christopher J Aylwin; Thomas C König; Nora W Brennan; Peter J Shirley; Gareth Davies; Michael S Walsh; Karim Brohi
Journal:  Lancet       Date:  2006-12-23       Impact factor: 79.321

3.  Paris terrorist attack: early lessons from the intensivists.

Authors: 
Journal:  Crit Care       Date:  2016-04-08       Impact factor: 9.097

4.  Tactical emergency medicine: lessons from Paris marauding terrorist attack.

Authors: 
Journal:  Crit Care       Date:  2016-02-13       Impact factor: 9.097
  4 in total
  3 in total

Review 1.  Triage.

Authors:  Michael D Christian
Journal:  Crit Care Clin       Date:  2019-07-27       Impact factor: 3.598

2.  Mental health impact among hospital staff in the aftermath of the Nice 2016 terror attack: the ECHOS de Nice study.

Authors:  Laurence Bentz; Stéphanie Vandentorren; Roxane Fabre; Jeremy Bride; Philippe Pirard; Nadège Doulet; Thierry Baubet; Yvon Motreff; Christian Pradier
Journal:  BMC Public Health       Date:  2021-07-10       Impact factor: 3.295

3.  Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients.

Authors:  Julien Pottecher; Eric Noll; Marie Borel; Gérard Audibert; Sébastien Gette; Christian Meyer; Elisabeth Gaertner; Vincent Legros; Raphaël Carapito; Béatrice Uring-Lambert; Erik Sauleau; Walter G Land; Seiamak Bahram; Alain Meyer; Bernard Geny; Pierre Diemunsch
Journal:  Trials       Date:  2020-03-18       Impact factor: 2.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.